Newport Beach, CALIFORNIA4 Active Studies

Pulmonary Hypertension Clinical Trials in Newport Beach, CALIFORNIA

Find 4 actively recruiting pulmonary hypertension clinical trials in Newport Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
758
Enrolling

Recruiting Pulmonary Hypertension Studies in Newport Beach

RecruitingNewport Beach, CALIFORNIANCT06750289

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated with medium-dose ICS-LABA compared to the conventional treatm...

400 participants
AstraZeneca
View Study Details
RecruitingNewport Beach, CALIFORNIANCT06029270

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come back after a period of improvement (recurre...

156 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNewport Beach, CALIFORNIANCT05503264

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

The purpose of this study is to assess the efficacy, safety, PK, and PD of satralizumab in participants with NMDAR and LGI1 encephalitis....

152 participants
Hoffmann-La Roche
View Study Details
RecruitingNewport Beach, CALIFORNIANCT05904080

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of impro...

50 participants
National Cancer Institute (NCI)
View Study Details

About Pulmonary Hypertension Clinical Trials in Newport Beach

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 4 pulmonary hypertension clinical trials recruiting participants in Newport Beach, CALIFORNIA. These studies are seeking a combined 758 participants. Research is being sponsored by AstraZeneca, National Cancer Institute (NCI), Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Newport Beach — FAQ

Are there pulmonary hypertension clinical trials in Newport Beach?

Yes, there are 4 pulmonary hypertension clinical trials currently recruiting in Newport Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 4 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated March 2, 2026 from ClinicalTrials.gov